This story has been updated with additional comments from Datavant. Health tech company Datavant is making moves to be a bigger player in the real-world data space. The company announced Thursday that ...

Data breaches and malware may get all the attention but real-world threats can do just as much damage, especially when you’re ...

I rely on data for clarity and risk transparency, but instinct shapes how I interpret it. My approach combines analytical ...

The rise in direct-to-patient therapeutics access via online compounding pharmacies and other direct-to-patient sales models has increased the likelihood of patients utilizing medications alongside ...

Thanks to new regulatory frameworks like the Food and Drug Administration’s Breakthrough Therapy designation, drugs are coming to market faster than ever. A 2024 analysis of drugs included in this ...

First, institutions must ensure that synthetic datasets are continuously recalibrated against fresh, real-world evidence. The ...

Benign prostatic hyperplasia (BPH) is one of the most common urologic conditions affecting men as they age, with nearly 50% of men over 50 experiencing symptoms. Despite its prevalence, treatment ...

With more than 2,000 citations and year-over-year growth nearing 80%, TriNetX outpaces competitors and fuels high-impact science published in top medical journals. CAMBRIDGE, Mass., Oct. 15, 2025 ...

Tesla’s autonomous driving project has quietly crossed a threshold that matters far beyond bragging rights. With its Full ...

Jeffrey Stark, MD, vice president, head of medical immunology, UCB, discusses ongoing clinical trials and the development of real-world data to understand the effectiveness of bimekizumab-bkzx in a ...

The Tesla Semi has been a long-running project for the electric automaker. As is the Tesla way, the company has promised big things long ahead of the product actually reaching the market. Now, we’re ...

Delayed IPF diagnosis often results in significant lung function impairment, impacting patient outcomes and increasing hospitalization rates. Antifibrotic therapies, nintedanib and pirfenidone, are ...